Genentech, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
Other Names/Subsidiaries
- Tanox
Latest on Genentech, Inc.
Oncology sponsors will face increased US Food and Drug Administration scrutiny about patient enrollment and site selection for multiregional trials, as well as the relevance of comparator arms to US s
Roche affiliate Genentech revealed on July 18 that the US Food and Drug Administration denied a supplemental approval for its bispecific antibody Columvi (glofitamab-gxbm) in relapsed/refractory diffu
BioBytes presents an overview of select AI-focused M&As, partnerships and financings in the biopharma industry in Q2 2025. While the flow of money was mostly anemic, a couple of standouts are a $2
The US Centers for Medicare and Medicaid Services’ proposal to select certain fixed-dose drug combinations for Medicare price negotiation is “impermissibly” at odds with the US Food and Drug Administr